PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30836143-0	2019	Omega-3 fatty acids and docosahexaenoic acid oxymetabolites modulate the inflammatory response of equine recombinant interleukin1beta-stimulated equine synoviocytes.	Fatty Acids, Omega-3	0-19	interleukin-1 beta	Equus caballus	117-133	
30836143-0	2019	Omega-3 fatty acids and docosahexaenoic acid oxymetabolites modulate the inflammatory response of equine recombinant interleukin1beta-stimulated equine synoviocytes.	Docosahexaenoic Acids	24-44	interleukin-1 beta	Equus caballus	117-133	
30836143-4	2019	We hypothesized that n-3 PUFA and selected docosanoids would modulate inflammatory mediator gene expression by recombinant equine (re)IL-1beta-stimulated synovial fibroblasts.	Fatty Acids, Omega-3	21-29	interleukin 1 alpha	Equus caballus	134-142	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	Eicosapentaenoic Acid	38-41	ADAM metallopeptidase with thrombospondin type 1 motif 4	Equus caballus	128-135	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	Eicosapentaenoic Acid	38-41	MMP-1	Equus caballus	137-142	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	Eicosapentaenoic Acid	38-41	matrix metallopeptidase 13	Equus caballus	144-150	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	Eicosapentaenoic Acid	38-41	interleukin 6	Equus caballus	162-166	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	Eicosapentaenoic Acid	38-41	cytochrome c oxidase subunit II	Equus caballus	171-176	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	Docosahexaenoic Acids	45-48	ADAM metallopeptidase with thrombospondin type 1 motif 4	Equus caballus	128-135	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	Docosahexaenoic Acids	45-48	MMP-1	Equus caballus	137-142	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	Docosahexaenoic Acids	45-48	matrix metallopeptidase 13	Equus caballus	144-150	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	Docosahexaenoic Acids	45-48	interleukin 6	Equus caballus	162-166	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	Docosahexaenoic Acids	45-48	cytochrome c oxidase subunit II	Equus caballus	171-176	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	reil-1beta	61-71	ADAM metallopeptidase with thrombospondin type 1 motif 4	Equus caballus	128-135	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	reil-1beta	61-71	MMP-1	Equus caballus	137-142	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	reil-1beta	61-71	matrix metallopeptidase 13	Equus caballus	144-150	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	reil-1beta	61-71	interleukin 6	Equus caballus	162-166	
30836143-9	2019	Synoviocyte cultures pre-treated with EPA or DHA followed by reIL-1beta stimulation had significant reductions in expression of ADAMTS4, MMP-1, MMP-13, IL-1beta, IL-6 and COX-2.	reil-1beta	61-71	cytochrome c oxidase subunit II	Equus caballus	171-176